Αποτελέσματα Αναζήτησης
Δισκίο, επικαλυμμένο με υμένιο. Αναλυτικές πληροφορίες συστατικών, κυκλοφορίας και τρόπου χρήσης του φαρμάκου ELIQUIS.
30 Μαρ 2017 · In this randomized, double-blind, phase 3 study, we assigned 3396 patients with venous thromboembolism to receive either once-daily rivaroxaban (at doses of 20 mg or 10 mg) or 100 mg of...
Apixaban (Eliquis®) is a direct oral anticoagulant agent, that highly selective active site inhibitor of factor Xa, administered as 5 mg twice daily and reduced to 2.5 mg in certain cases, and its biopharmaceutics classification system (BCS) is class Ⅲ, as good soluble poor permeable substances (Bell et al., 2009, EMC, 2022, Lexicomp, , 2022 ...
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS ® (apixaban) if: You have not previously filled a prescription for ELIQUIS; You have a valid 30-day prescription for ELIQUIS;
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS ® (apixaban) if: You have not previously filled a prescription for ELIQUIS; You have a valid 30-day prescription for ELIQUIS;
Eliquis FREE 30-day Trial. Eligible patients may receive a FREE 30-day supply (up to 74 tablets); limited to one use per patient per lifetime. Applies to: Eliquis Number of uses: One-time offer Expires December 31, 2024. Form more information phone: 855-354-7847 or Visit website
ELIQUIS Free Trial Ofer. With the ELIQUIS Free Trial Offer, eligible* first-time patients can receive a free 30-day supply. To receive an ELIQUIS Free Trial Ofer, please request one from your healthcare professional. To activate, visit ELIQUIS.com or call. 1-855-ELIQUIS (354-7847). *See eligibility requirements and terms of use.
